Skip to main content

PROSER1 Antibody [HRP]

Novus Biologicals, part of Bio-Techne | Catalog # NBP3-05784H

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP3-05784H

Key Product Details

Species Reactivity

Validated:

Human

Applications

Immunocytochemistry/ Immunofluorescence

Label

HRP

Antibody Source

Polyclonal Rabbit IgG

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Product Summary for PROSER1 Antibody [HRP]

Immunogen

Produced in rabbits immunized with E. coli-derived Human PROSER1 fragment.

Clonality

Polyclonal

Host

Rabbit

Isotype

IgG

Applications for PROSER1 Antibody [HRP]

Application
Recommended Usage

Immunocytochemistry/ Immunofluorescence

Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Antigen and protein A Affinity-purified

Formulation

PBS

Preservative

No Preservative

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C in the dark.

Background: PROSER1

Alternate Names

C13orf23, Chromosome 13 Open Reading Frame 23, KIAA2032, Proline And Serine Rich 1, Proline And Serine-Rich Protein 1

Gene Symbol

PROSER1

Additional PROSER1 Products

Product Documents for PROSER1 Antibody [HRP]

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for PROSER1 Antibody [HRP]

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...